Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting

Annals of the Rheumatic Diseases

Volumn 71, Issue 7, 2012, Pages 1122-1127

  Nordal, E B ^a,b   Zak, M ^c   Aalto, K ^d   Berntson, L ^e   Fasth, A ^f   Herlin, T ^g   Lahdenne, P ^d   Nielsen, S ^c   Peltoniemi, S ^d   Straume, B ^b   Rygg, M ^h,i  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UPPSALA UNIVERSITY   (Sweden)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

ⁱ TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ARTICLE; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONSTRUCT VALIDITY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DRUG USE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JUVENILE ARTHRITIS DISEASE ACTIVITY SCORE; JUVENILE RHEUMATOID ARTHRITIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN; PHYSICAL DISABILITY; POPULATION RESEARCH; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY ANALYSIS;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; DISABILITY EVALUATION; FEMALE; HUMANS; JOINTS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84862574205     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200237     Document Type: Article

References (30)

1. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2. (Pubitemid 38160763)
2. Consolaro A, Ruperto N, Bazso A, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009;61:658-66.
3. Bazso A, Consolaro A, Ruperto N, et al. Development and testing of reduced joint counts in juvenile idiopathic arthritis. J Rheumatol 2009;36:183-90.
4. Ringold S, Bittner R, Neogi T, et al. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: Analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease. Arthritis Care Res (Hoboken) 2010;62:1095-102.
5. Giannini EH, Ruperto N, Ravelli A, et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9. (Pubitemid 27430130)
6. Lovell DJ, Ruperto N, Goodman S, et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008;359:810-20.
7. Berntson L, Wernroth L, Fasth A, et al. Assessment of disease activity in juvenile idiopathic arthritis. The number and the size of joints matter. J Rheumatol 2007;34:2106-11. (Pubitemid 47548219)
8. Bandeira M, Falcone A, Pistorio A, et al. Weighting improves the information provided by joint counts on the severity of arthritis and its impact on patients' well-being in juvenile idiopathic arthritis. Rheumatology (Oxford) 2006;45:343-7. (Pubitemid 43372852)
9. Nordal E, Zak M, Aalto K, et al. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 2011;63:2809-18.
10. Berntson L, Andersson Gäre B, Fasth A, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 2003;30:2275-82.
11. Viola S, Felici E, Magni-Manzoni S, et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum 2005;52:2092-102. (Pubitemid 40994332)
12. Ruperto N, Ravelli A, Pistorio A, et al. Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol 2001;19:S1-9. (Pubitemid 33730178)
13. Selvaag AM, Ruperto N, Asplin L, et al. The Norwegian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19:S116-20. (Pubitemid 33730200)
14. Nielsen S, Ruperto N, Herlin T, et al. The Danish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19:S50-4. (Pubitemid 33730187)
15. Pelkonen P, Ruperto N, Honkanen V, et al. The Finnish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19:S55-9. (Pubitemid 33730188)
16. Andersson Gäre B, Ruperto N, Berg S, et al. The Swedish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19:S146-50.
17. Fries JF, Spitz P, Kraines RG, et al. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45. (Pubitemid 10164318)
18. Landgraf JM, Abetz L WJ. The CHQ User's Manual. Boston, Maryland: The Health Institute, New England Medical Center, 1996:235-9.
19. Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290-4. (Pubitemid 39453253)
20. Liang MH, Larson MG, Cullen KE, et al. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985;28:542-7. (Pubitemid 15109906)
21. Cohen J. Statistical Power Analysis for the Behavioural Sciences. New York: Academic Press, 1977.
22. Hosmer D, Lemeshow S. Applied Logistic Regression. Second edition. New York: John Wiley & Sons, 2000.
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10. (Pubitemid 16134762)
24. Laurell L, Court-Payen M, Nielsen S, et al. Ultrasonography and color Doppler in juvenile idiopathic arthritis: diagnosis and follow-up of ultrasound-guided steroid injection in the ankle region. A descriptive interventional study. Pediatr Rheumatol Online J 2011;9:4.
25. Wells G, Becker JC, Teng J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 2009;68:954-60.
26. Crowson CS, Rahman MU, Matteson EL. Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis. J Rheumatol 2009;36:1606-10.
27. Saadeh C. The erythrocyte sedimentation rate: old and new clinical applications. South Med J 1998;91:220-5. (Pubitemid 28227583)
28. Amezcua-Guerra LM, Castillo-Martinez D, Bojalil R. The story behind the acute-phase reactants. J Rheumatol 2010;37:469.
29. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997;24:1477-85. (Pubitemid 27320685)
30. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Kerstens PJ, et al. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis. Ann Rheum Dis 2010;69:65-9.